Thomas Shook, M.D., F.A.C.C., F.A.H.A., is a distinguished physician executive, board-certified interventional cardiologist, clinical development strategist, and healthcare leader whose career spans more than four decades of transformative contributions to medicine, healthcare operations, pharmaceutical development, and global clinical research. Throughout his professional journey, Dr. Shook has consistently demonstrated an exceptional ability to bridge the worlds of patient care, scientific innovation, and executive leadership, creating lasting impact across healthcare systems, research organizations, pharmaceutical companies, and medical institutions around the world.
Dr. Shook’s passion for medicine began with a strong academic foundation. He earned his Bachelor of Arts degree from Harvard University before pursuing his Doctor of Medicine degree at the University of Kansas School of Medicine. His postgraduate medical training included an internship and residency in Internal Medicine at Massachusetts General Hospital, followed by an elite Clinical and Research Fellowship in Cardiology at Brigham and Women’s Hospital and Harvard Medical School. These formative experiences placed him among some of the nation’s most respected physicians and researchers, helping shape a career grounded in scientific rigor, compassionate care, and lifelong learning.
Early in his career, Dr. Shook developed a reputation as both a talented clinician and an innovative researcher. As an Associate Physician at Brigham and Women’s Hospital and an Instructor in Medicine at Harvard Medical School, he contributed to advancing the understanding of cardiovascular disease and participated in groundbreaking clinical research initiatives. His work during this period laid the foundation for a lifelong commitment to evidence-based medicine and clinical innovation that would later define his executive leadership philosophy.
In 1987, Dr. Shook relocated to Los Angeles and became a Partner with Los Angeles Cardiology Associates, launching a highly successful twenty-year career in clinical and interventional cardiology. During this time, he built an extensive practice focused on delivering exceptional cardiovascular care while simultaneously establishing one of the region’s most productive clinical research programs. As Principal Investigator or Co-Principal Investigator on more than seventy-five clinical trials, he played a critical role in evaluating emerging therapies, technologies, and treatment strategies that would ultimately improve outcomes for countless patients worldwide.
Beyond his clinical practice, Dr. Shook became an influential healthcare leader within Good Samaritan Hospital in Los Angeles. Over two decades of service, he held numerous leadership positions, including Director of the Acute Myocardial Intervention Program, Director of the Coronary Care Unit, Chairman of the Critical Care Committee, Vice Chairman and Chairman of the Medical Staff, and Member of the Board of Directors. Through these roles, he helped guide strategic initiatives, enhance clinical quality standards, and strengthen organizational governance while contributing to the hospital’s growth as a premier regional cardiovascular referral center.
After establishing himself as a respected physician leader, Dr. Shook embarked on a new chapter in 2008 when he joined PAREXEL International, one of the world’s leading contract research organizations. Transitioning from clinical practice into global healthcare leadership, he brought a unique combination of physician insight, operational expertise, and strategic vision. As Senior Medical Director, he advised pharmaceutical, biotechnology, and medical device clients on clinical development strategies, regulatory pathways, medical affairs, and scientific innovation throughout the product development lifecycle.
His leadership responsibilities expanded significantly when he was appointed Corporate Vice President and Head of Global Medical Services. In this role, Dr. Shook led an organization of more than 125 physicians and over 650 healthcare professionals responsible for medical monitoring, pharmacovigilance, endpoint adjudication, medical writing, and scientific consulting services supporting more than 600 clinical trials globally. His tenure was marked by meaningful innovation, including the development of enhanced therapeutic area training programs, advanced medical data surveillance methodologies, improved pharmacovigilance processes, and broader access to specialized medical expertise across international markets.
Dr. Shook’s success in leading large-scale global operations culminated in his appointment as Executive Vice President of Clinical Research Services and Senior Medical Officer at PAREXEL. In this executive role, he provided strategic oversight for critical clinical research functions while helping shape corporate growth strategies and industry partnerships. He worked closely with pharmaceutical companies, biotechnology innovators, academic institutions, and medical device developers to foster collaboration and accelerate the development of therapies that improve human health. His ability to align scientific excellence with business objectives earned him recognition as a trusted advisor and influential leader throughout the life sciences industry.
Throughout his career, Dr. Shook has maintained a deep commitment to advancing medical knowledge through research and publication. He has authored or co-authored more than twenty-five peer-reviewed scientific publications, including contributions to prestigious journals such as The New England Journal of Medicine, Circulation, the Journal of the American College of Cardiology, and the American Journal of Medicine. His research has addressed critical issues in cardiology, clinical trial methodology, drug safety, cardiovascular intervention, and emerging healthcare technologies. His work has influenced both clinical practice and pharmaceutical development while helping establish new standards for patient care and scientific investigation.
In addition to his published research, Dr. Shook has become a respected voice within the global healthcare community through conference presentations, executive leadership forums, and industry discussions. He has spoken on topics ranging from clinical trial innovation and regulatory strategy to wearable technologies and digital health solutions. His ability to translate complex scientific concepts into actionable business and healthcare strategies has made him a valued contributor to both medical and executive audiences.
Today, Dr. Shook serves as Principal Consultant of Bright Night Consulting, LLC, where he advises clients across healthcare, biotechnology, pharmaceutical development, financial services, and medical technology sectors. Drawing upon decades of leadership experience, he provides guidance in strategic planning, clinical development, medical affairs, regulatory strategy, risk management, organizational growth, and operational excellence. His consulting work reflects his enduring passion for helping organizations navigate complexity, capitalize on innovation, and achieve sustainable success.
Dr. Shook’s global perspective further strengthens his value as a business leader and board advisor. Having worked extensively throughout Europe, Latin America, and the Asia-Pacific region, he possesses a nuanced understanding of international healthcare systems, regulatory environments, and cultural dynamics. Combined with conversational proficiency in Spanish and German, this international experience enables him to effectively engage diverse stakeholders and contribute to organizations operating across global markets.
As a board candidate, Dr. Shook offers a rare combination of clinical expertise, executive leadership, governance experience, and strategic vision. His service on hospital boards, leadership of multinational healthcare organizations, oversight of large-scale clinical operations, and extensive involvement in drug and device development provide him with a unique ability to help organizations manage growth, assess risk, drive innovation, and create long-term value. He is motivated by a genuine desire to help organizations succeed while improving outcomes for patients, healthcare providers, and stakeholders alike.
Throughout every stage of his career, Dr. Shook has remained guided by a commitment to excellence, integrity, collaboration, and service. Whether caring for patients, leading global teams, conducting research, or advising executive leadership, he has consistently focused on creating meaningful impact. His legacy reflects not only an extraordinary professional journey but also a dedication to advancing healthcare and empowering organizations to achieve their highest potential.
Character:
Dr. Shook demonstrates unwavering integrity in every aspect of his professional and personal life. He is respected for his ethical decision-making, accountability, and commitment to serving others. His leadership style reflects humility, professionalism, and a genuine desire to help organizations and individuals succeed.
Knowledge:
He possesses exceptional expertise across clinical medicine, pharmaceutical development, healthcare operations, and clinical research. His decades of experience provide him with a deep understanding of both scientific innovation and business strategy. He continuously applies his knowledge to solve complex challenges and guide organizations toward informed decisions.
Strategic:
Dr. Shook has repeatedly demonstrated the ability to align long-term vision with operational execution. He understands how to evaluate opportunities, manage risk, and position organizations for sustainable growth. His leadership experience across healthcare systems, clinical research organizations, and consulting engagements reflects a highly strategic mindset.
Communication:
An effective communicator who can engage audiences ranging from clinicians and researchers to executives, investors, and board members. He excels at translating complex medical and scientific information into practical business insights. His collaborative approach fosters trust, alignment, and productive decision-making across diverse stakeholder groups.
